Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

Uyoga, Sophie, Adetifa, Ifedayo M. O., Karanja, Henry K., Nyagwange, James, Tuju, James, Wanjiku, Perpetual, Aman, Rashid, Mwangangi, Mercy +31 more·2021·Science
DOI 10.1126/science.abe1916

Cited by (290)

Items 101–200 of 290

  1. Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
    Lisa Weidner, Verena Nunhofer, Christof Jungbauer, Alexandra Domnica Hoeggerl, Lydia Grüner, Christoph Grabmer, Georg Zimmermann, Eva Rohde, Sandra Laner‐Plamberger · 2021 · Infection
  2. Adapting Longstanding Public Health Collaborations between Government of Kenya and CDC Kenya in Response to the COVID-19 Pandemic, 2020–2021
    2022
  3. Temporal lineage replacements and dominance of imported variants of concern during the COVID-19 pandemic in Kenya
    Gathii Kimita, Josphat Nyataya, Esther Omuseni, Faith Sigei, Allan P. Lemtudo, Eric M. Muthanje, Brian Andika, Rehema Liyai, Rachel Githii, Clement Masakhwe et al. · 2022 · Communications Medicine
  4. Prevalence of SARS-CoV-2 and co-infection with malaria during the first wave of the pandemic (the Burkina Faso case)
    Diana López‐Farfán, Rakiswendé Serge Yerbanga, Marina Parres-Mercader, Manuela Torres‐Puente, Inmaculada Gómez-Navarro, Do Malick Soufiane Sanou, Adama Franck Yao, Jean‐Bosco Ouédraogo, Iñaki Comas, Nerea Irigoyen et al. · 2022 · Frontiers in Public Health
  5. Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020
    Enyew Birru Tadese, Abduilhafiz Assen Endris, Henok Solomon, Mikias Alayu, Adisu Kebede, Kirubel Eshetu, Gizaw Teka, Biniyam Eskinder, Jelaludin Ahmed, Sisay Abayneh et al. · 2021 · International Journal of Infectious Diseases
  6. SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020
    Joe Theu, Alinune Nathanael Kabaghe, George Bello, Evelyn Chitsa-Banda, Matthew Kagoli, Andrew F. Auld, Jonathan Mkungudza, Gabrielle O’Malley, Fred Fredrick Bangara, Elizabeth Fleur Peacocke et al. · 2022 · Emerging infectious diseases
  7. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020
    Jaya A. George, Siyabonga P. Khoza, Elizabeth Sarah Mayne, Sipho Dlamini, Ngalula Kone, Waasila Jassat, Kamy Chetty, Chad M. Centner, Taryn Pillay, Mpho R. Maphayi et al. · 2021 · South African Medical Journal
  8. Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya
    Eunice Wangeci Kagucia, John N. Gitonga, Catherine Kalu, Eric Ochomo, Benard Omondi Ochieng, Nickline A. Kuya, Angela Karani, James Nyagwange, Boniface Karia, Daisy Mugo et al. · 2021 · Open Forum Infectious Diseases
  9. Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study
    Charles N. Agoti, Lynette Isabella Ochola‐Oyier, Simon Dellicour, Khadija Said Mohammed, Arnold W. Lambisia, Zaydah R. de Laurent, John Mwita Morobe, Maureen W. Mburu, Donwilliams O. Omuoyo, Edidah M. Ong’era et al. · 2022 · eLife
  10. SARS-CoV-2 Seroprevalence in a University Community: A Longitudinal Study of the Impact of Student Return to Campus on Infection Risk Among Community Members
    2021
  11. Air transportation as a puzzle piece of COVID-19 in Africa?
    Xiaoqian Sun, Sebastian Wandelt, Anming Zhang · 2022 · Research in Transportation Business & Management
  12. Seroprevalence of human coronaviruses among patients visiting hospital-based sentinel sites in Uganda
    Elijah N. Mulabbi, Robert Tweyongyere, Fred Wabwire‐Mangen, Edison Arwanire Mworozi, Jeff Koehlerb, Hannah N. Kibuuka, Monica Millard, Bernard Erima, Titus Tugume, Qouilazoni A. Ukuli et al. · 2021 · BMC Infectious Diseases
  13. The genomic epidemiology of SARS-CoV-2 variants of concern in Kenya
    George Githinji, Arnold W. Lambisia, Ifeanyi F. Omah, Aine Niamh O’Toole, Khadija Said Mohammed, Zaydah R. de Laurent, Timothy Makori, Mike J. Mwanga, Maureen W. Mburu, John Mwita Morobe et al. · 2022 · medRxiv
  14. Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020–21
    Ruth Khadembu Lucinde, Daisy Mugo, Christian Bottomley, Angela Karani, Elizabeth Gardiner, Rabia Aziza, John N. Gitonga, Henry Karanja, James Nyagwange, James Tuju et al. · 2022 · PLoS ONE
  15. Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria
    Kesego Tapela, Diana Ahu Prah, Becky Ewurama Tetteh, Franklin Yengdem Nuokpem, Daniel Dosoo, Amin Coker, Frederick Kumi-Ansah, Emmanuella Faith Amoako, Kissi Ohene Assah, Charlyne Kilba et al. · 2024 · Cell Reports
  16. SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022
    Evan M. Bloch, Dorothy Kyeyune, Jodie L. White, H. Ddungu, Swetha Ashokkumar, F. Habtehyimer, O. Baker, R. Kasirye, E. Patel, M. K. Grabowski et al. · 2023 · Transfusion
  17. Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications
    Hasan Sulaeman, Eduard Grebe, Honey Dave, Lily McCann, Clara Di Germanio, Aditi Sanghavi, Victoria Sclar, Daniel W. Bougie, Garrick Chatelain, Brad J. Biggerstaff et al. · 2023 · Microbiology Spectrum
  18. Seroprevalence of anti-SARS-CoV-2 antibodies in a population living in Bomassa village, Republic of Congo
    Lobaloba Ingoba, Line, Djontu, Jean Claude, Mfoutou Mapanguy, Claujens Chastel, Mouzinga, Freisnel, Diafouka Kietela, Steve, Vouvoungui, Christevy, Kuisma, Eeva, Nguimbi, Etienne, Ntoumi, Francine · 2022 · IJID Regions
  19. Saliva-based methods for SARS-CoV-2 testing in low- and middle-income countries
    2022
  20. Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases
    Sarah E. Gwyn, Ado G. Abubakar, Oluwaseun O. Akinmulero, Éric Bergeron, Nkechi Blessing Ugboaja, Jasmine M. Chaitram, Melissa M. Coughlin, Ayuba Bulus Dawurung, Felicia Nwatu, Mudiaga K. Esiekpe et al. · 2022 · American Journal of Tropical Medicine and Hygiene
  21. Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
    John Ojal, Samuel P. C. Brand, Vincent Omondi Were, Emelda A. Okiro, Ivy K. Kombe, Caroline Mburu, Rabia Aziza, Morris Ondieki Ogero, Ambrose Agweyu, George M. Warimwe et al. · 2022 · Wellcome Open Research
  22. Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020
    2021
  23. Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity
    Minakshi Mishra, Rajan Chaudhry, Farah Rana, Deb Sanjay Nag, Sudhir Rai · 2021 · Cureus
  24. Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
    James Nyagwange, Bernadette Kutima, Kennedy Mwai, Henry Karanja, John N. Gitonga, Daisy Mugo, Yiakon Sein, Daniel Wright, Donwilliams O. Omuoyo, Joyce Uchi Nyiro et al. · 2022 · International Journal of Infectious Diseases
  25. Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana
    2021
  26. Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology
    Lucy B. Ochola, Paul Ogongo, Samuel Mungai Mbugua, Jesse Gitaka, Sara Suliman · 2021 · Clinics in Laboratory Medicine
  27. Representative Estimates of COVID-19 Infection Fatality Rates from Three Locations in India
    2021
  28. Rethinking the evidence on COVID-19 in Africa
    Philip Bejon, Ambrose Agweyu, Lynette Isabella Ochola‐Oyier, Mainga Hamaluba, Dorcas Kamuya, Samson Kinyanjui, Edwine Barasa · 2025 · The Lancet Infectious Diseases
  29. Revealing the extent of the COVID-19 pandemic in Kenya based on serological and PCR-test data
    2020
  30. SARS-CoV-2 serosurveys in low-income and middle-income countries
    Jean Claude Mugunga, Kartik Tyagi, Daniel Bernal-Serrano, Nidia E. Correa, Matias Iberico, Frederick Kateera, Fernet Renand Leandre, Megan B. Murray, Jean Christophe Dimitri Suffrin, Bethany Hedt‐Gauthier · 2021 · The Lancet
  31. SARS-CoV-2 serosurvey among adults involved in healthcare and health research in Guinea-Bissau, West Africa
    Christine Stabell Benn, Alberto Salinha, S. Mendes, Carlos Henrique Pereira de Souza Cabral, Cesário Lorenco Martins, Sebastian Nielsen, Ane Bærent Fisker, Frederik Schaltz‐Buchholzer, Charlotte Sværke Jørgensen, Peter Aaby · 2021 · Public Health
  32. Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
    Doreen I. Lugano, Bernadette Kutima, Makobu Kimani, Antipa K. Sigilai, John N. Gitonga, Angela Karani, Donald O. Akech, Boniface Karia, Abdhalah Kasiira Ziraba, Angela W. Maina et al. · 2024 · BMC Infectious Diseases
  33. Distinct antibody responses to endemic coronaviruses pre- and post-SARS-CoV-2 infection in Kenyan infants and mothers
    2022
  34. Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand
    Lauren H. Carlton, Tiffany Chen, Alana L. Whitcombe, Reuben McGregor, Greg Scheurich, Campbell R. Sheen, James M. J. J. Dickson, Chris Bullen, Annie Chiang, Daniel John Exeter et al. · 2021 · Epidemiology and Infection
  35. Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
    Amandine Mveang Nzoghe, Marielle Leboueny, Éliane Kuissi Kamgaing, Anicet Christel Maloupazoa Siawaya, Eliode Cyrien Bongho, Ofilia Mvoundza Ndjindji, Guy-Stephan Padzys, Bénédicte Ndeboko, S. Ategbo, Joël Fleury Djoba Siawaya · 2021 · BMC Research Notes
  36. Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
    Marc Emmenegger, Elena De Cecco, David Lamparter, Raphaël P. B. Jacquat, Julien Riou, Dominik Menges, Tala Ballouz, Daniel V. Ebner, Matthias M. Schneider, Itzel Condado Morales et al. · 2023 · iScience
  37. Genomic epidemiology of SARS-CoV-2 infections in The Gambia: an analysis of routinely collected surveillance data between March, 2020, and January, 2022
    Abdoulie Kanteh, Haruna S. Jallow, Jarra Manneh et al. · 2023 · The Lancet Global Health
  38. SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review
    Samuel Alizon, Mircea T. Sofonea · 2025 · Virulence
  39. Representative estimates of COVID-19 infection fatality rates from four locations in India: cross-sectional study
    Rebecca Cai, Paul Michael Novosad, Vaidehi Tandel, Sam Asher, Anup Malani · 2021 · BMJ Open
  40. Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana
    Peter K. Quashie, Joe Kimanthi Mutungi, Francis Dzabeng, Daniel Oduro‐Mensah, Precious Chinonyerem Opurum, Kesego Tapela, Aniefiok John Udoakang, WACCBIP COVID-19 Team, Ivy Asantewaa Asante, Lily Paemka et al. · 2021 · Wellcome Open Research
  41. SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022
    Eunice Wangeci Kagucia, AK Ziraba, James Nyagwange, Bernadette Kutima, Makobu Kimani, Donald O. Akech, Maurine A. Ng’oda, Antipa K. Sigilai, Daisy Mugo, Henry Karanja et al. · 2022 · medRxiv
  42. Global, regional, and national estimates of target population sizes for COVID-19 vaccination
    2020
  43. Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
    Natalia Martínez-Acuña, Diana Minerva Avalos-Nolazco, Diana Raquel Rodríguez-Rodríguez, Cynthia Martinez-Liu, Rogelio Cázares-Tamez, Amador Flores-Aréchiga, Fernando Pérez‐Chávez, Sergio Ayala de la Cruz, Eduardo Cienfuegos‐Pecina, Erik Alejandro Díaz‐Chuc et al. · 2021 · Viruses
  44. Implementing Serosurveys in India: Experiences, Lessons Learned, and Recommendations
    2021
  45. Quantitative measurement of IgG to SARS‐CoV‐2 antigens using monoclonal antibody‐based enzyme‐linked immunosorbent assays
    Ingrid Sander, Sabine Kespohl, Eva Zahradnik, Philipp Göcke, Ingolf Hosbach, Burkhard Lorenz Herrmann, Thomas Brüning, Monika Raulf · 2022 · Clinical & Translational Immunology
  46. Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan
    Kiran Iqbal Masood, Shama Qaiser, Syed Hani Abidi, Erum Khan, Syed Faisal Mahmood, Areeba Hussain, Zara Ghous, Khekahsan Imtiaz, Natasha Bahadur Ali, Muhammad Saleem Hasan et al. · 2023 · BMC Infectious Diseases
  47. Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
    Clémentine Metzger, Taylor Leroy, Agathe Bochnakian, Hélène Jeulin, Anne Gégout‐Petit, Karine Legrand, Évelyne Schvoerer, Françis Guillemin · 2023 · PLoS ONE
  48. HIV and SARS-CoV-2 infection in postpartum Kenyan women and their infants
    Emily R. Begnel, Bhavna H. Chohan, Ednah Ojee, Judith Adhiambo, Prestone Owiti, Vincent Wayuga Ogweno, LaRinda A. Holland, Carolyn S. Fish, Barbra A. Richardson, Adam K. Khan et al. · 2023 · PLoS ONE
  49. Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review
    Sahar Saeed, Samra Uzicanin, Antoine Lewin, Ryanne W. Lieshout‐Krikke, Helen M. Faddy, Christian Erikstrup, Carla Osiowy, Clive R. Seed, Whitney Randolph Steele, Katy L. Davison et al. · 2021 · Vox Sanguinis
  50. Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern
    Ben Katowa, Annie Kalonda, Benjamin Mubemba, Japhet Matoba, Doreen Mainza Shempela, Jay Sikalima, Boniface Kabungo, Katendi Changula, Simbarashe Chitanga, Mpanga Kasonde et al. · 2022 · Viruses
  51. Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic
    2020
  52. Very High Relative Seroprevalence of Anti--SARS-CoV-2 Antibodies Among Communities in Bangui, Central African Republic
    2021
  53. Assessing and Minimizing the Effect of Malaria on SARS-CoV-2 Serodiagnostics
    2021
  54. COVID ‐19 by numbers ‐ infections, cases and deaths
    Harald Brüssow · 2020 · Environmental Microbiology
  55. SARS-CoV-2 Seroprevalence at an Urban Hospital in Haiti
    Robert Price, Jeffrey Cho, Scott Nelson · 2022 · Cureus
  56. Evolving Patterns in COVID-19: The Virus, its Variants and Infectivity-cum-Virulence
    Vinod Nikhra · 2021 · Biomedical Journal of Scientific & Technical Research
  57. Seroprevalence of anti-SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia: a facility-based surveillance
    Nega Assefa, Lemma Demissie Regassa, Zelalem Teklemariam, Joseph O. Oundo, Lola Madrid, Addisu Kebede, Yadeta Dessie, JAG Scott · 2021 · BMJ Open
  58. Strengthening serological studies: the need for greater geographical diversity, biobanking, and data-accessibility
    Arthur Menezes, Solohery Lalaina Razafimahatratra, Oghenebrume Wariri, Andrea L. Graham, Charlotte Jessica E. Metcalf · 2025 · Trends in Microbiology
  59. COVID-19 in Africa: preexisting immunity and HIV
    Jumari Snyman, Eduard Joachim Sanders, Thumbi Ndung’u · 2021 · AIDS
  60. Estimating the Percentage of a Population Infected with SARS-CoV-2 Using the Number of Reported Deaths: A Policy Planning Tool
    D. Feikin, M. Widdowson, K. Mulholland · 2020 · Pathogens
  61. Genomic surveillance reveals the spread patterns of SARS-CoV-2 in coastal Kenya during the first two waves
    2021
  62. Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
    Cruz S. Sebastião, Manuela Galangue, Celestina Gaston, Rui Van‐Dunen, Joltim Quivinja, Emiliana Lunbungululo, Domingos Alfredo, Alberto Sozinho, Alice Teixeira, Eunice Manico et al. · 2021 · BMC Infectious Diseases
  63. Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic
    Alexandre Manirakiza, Christian Noël Malaka, Jean de Dieu Longo, Brice Martial Yambiyo, Saint Calvaire Henri Diémer, Joella Namseneï, Cathy Sandra Gomelle Coti-Reckoundji, Modeste Bouhouda, Marie Roseline Darnycka Bélizaire, Jean-Baptiste Roungou et al. · 2023 · Journal of Public Health in Africa
  64. Regional comparisons of COVID reporting rates, burden, and mortality age-structure using auxiliary data sources
    Mollie M. Van Gordon, Lawrence M Mwananyanda, Christopher John Gill, Kevin A. McCarthy · 2021 · medRxiv
  65. Pre-existing IgG antibodies to HCoVs NL63 and OC43 Spike increased during the pandemic and after COVID-19 vaccination
    2025
  66. High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya
    Shehu Shagari Awandu, Alfred O. Ochieng, Benson Onyango, Richard Odongo Magwanga, Pamella Were, Angeline Atieno Ochung’, Fredrick Oluoch Okumu, Marceline Adhiambo Oloo, Jim Seth Katieno, Shirley Lidechi et al. · 2022 · PLoS ONE
  67. Estimating SARS-CoV-2 seroprevalence
    Samuel P. Rosin, Bonnie E. Shook‐Sa, Stephen R. Cole, Michael G. Hudgens · 2023 · Journal of the Royal Statistical Society Series A (Statistics in Society)
  68. Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study
    Katherine E. Gallagher, Joyce Uchi Nyiro, Charles N. Agoti, Eric K. Maitha, James Nyagwange, Angela Karani, Christian Bottomley, Nickson Murunga, George Githinji, Martin N. Mutunga et al. · 2023 · Influenza and Other Respiratory Viruses
  69. Alternative epidemic indicators for COVID-19 in three settings with incomplete death registration systems
    Ruth McCabe, Charles Whittaker, Richard J. Sheppard, Nada Abdelmagid, Aljaile Ahmed, Israa Zain Alabdeen, Nicholas F. Brazeau, Abd Elhameed Ahmed, Abdulla Salem Bin-Ghouth, Arran Hamlet et al. · 2023 · Science Advances
  70. Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal
    Bobby Brooke Herrera, Beth Chaplin, Souleymane Mboup, Adam Abdullahi, Michelle He, Sydney M. Fisher, Sulaimon Alani Akanmu, Charlotte Ajeong Chang, Donald J. Hamel, Ravindra K. Gupta et al. · 2025 · Frontiers in Public Health
  71. The evolution and interpretation of seroprevalence of SARS‐CoV ‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves
    Marion Vermeulen, Laurette Mhlanga, Wendy Sykes, Russell Cable, Charl Coleman, Nadia Pietersen, Ronél Swanevelder, Tanya Nadia Glatt, Jeremy Bingham, Karin van den Berg et al. · 2023 · Vox Sanguinis
  72. SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India
    Srinivasa Rao Chunchu, Ushasree Ravula, Vikram Kumar Gente, Srinivas Bacchu, S. Pandu Ranga Rao, Srujaleswari Mooli · 2022 · Indian Journal of Hematology and Blood Transfusion
  73. Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers
    Michael N Brant-Zawadzki, Deborah Fridman, Philip A Robinson, Matthew Zahn, Clayton Chau, Randy German, Marcus Breit, Elmira Burke, Jason R. Bock, Junko Hara · 2021 · Open Forum Infectious Diseases
  74. SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis
    Greco Mark Malijan, Tansy Edwards, Kristal An Agrupis, Shuichi Suzuki, Annavi Marie G. Villanueva, Ana Ria Sayo, Ferdinand De Guzman, Alexis Q. Dimapilis, Rontgene Solante, Elizabeth O. Telan et al. · 2022 · Tropical Medicine and Health
  75. Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels
    2021
  76. Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria
    Ijeoma Maryjoy Ifeorah, Emmanuel Okechukwu Nna, Uchenna Okeke, Emo A. Ivo, Ojor Ayemoba, Thairu Yunusa, Ogbeche Richard Ochagu, Ngozi Immaculata Ugwu, Henrietta Uchenna Okafor, Amaka Obiageli Nnamani et al. · 2021 · Research Square
  77. Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced Cambodians
    2021
  78. Determinants of COVID-19 Vaccine Uptake and Acceptability in the Horn of Africa: Evidence from Somaliland
    2022
  79. Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study
    2021
  80. Epidemiological and antigenic inferences from serological cross-reactivity among arboviruses
    Megan O’Driscoll, Nathanaël Hozé, Noémie Lefrancq, Gabriel Ribeiro dos Santos, Damien Hoinard, Mohammed Ziaur Rahman, Kishor Kumar Paul, Abu Mohd Naser, Mohammad Shafiul Alam, Mohammad Enayet Hossain et al. · 2025 · Science Translational Medicine
  81. Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic
    Maher A. Sughayer, Asem H. Mansour, Abeer Al Nuirat, Lina Souan, Mohammad A. Ghanem, Mahmoud Siag, Sallam Alhassoon · 2021 · International Journal of Infectious Diseases
  82. Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021
    2021
  83. SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): a cross-sectional multistage household survey after the first epidemic wave, 2020
    2022
  84. Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
    Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, Peter Buttaroni, Anne-Linda Camerini, Laurie Corna, Sara Levati, Marta Fadda, Maddalena Fiordelli, Anna Maria Annoni et al. · 2023 · International Journal of Environmental Research and Public Health
  85. The Use of Residual Blood Specimens in Seroprevalence Studies for Vaccine-Preventable Diseases: A Scoping Review
    Monica Pilewskie, Christine Prosperi, Abigail Bernasconi · 2025 · Vaccines
  86. Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina
    Božo Šušak, Vinka Mikulić, Armina Lazarević, Ivanka Mikulić, Jurica Arapović · 2021 · Biomolecules and Biomedicine
  87. Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence
    2021
  88. Impact of the COVID-19 epidemic on mortality in rural coastal Kenya
    M. Otiende, A. Nyaguara, C. Bottomley, D. Walumbe, G. Mochamah, D. Amadi, C. Nyundo, E. Kagucia, A. Etyang, I. Adetifa et al. · 2022 · medRxiv
  89. Saliva-based SARS-CoV-2 serology using at-home collection kits returned via mail
    Christopher Campbell, Douglas W. Roblin, Nikhil Padmanabhan, Daniel Romero, Jessica Joe, Lily Fathi, Thomas Whiting, Jared N. Williamson, Paul Goodwin, Charmaine Mckie et al. · 2022 · Scientific Reports
  90. Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets
    2021
  91. COVID-19 immunization threshold(s): an analysis
    Luis Alfredo Bautista Balbás, Mario Gil-Conesa, Blanca Bautista Balbás, Ainhoa Alcaide Jiménez, Gil Rodríguez‐Caravaca · 2021 · medRxiv
  92. Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana
    Julia Meyer, Jennifer Nadal, Linda Batsa Debrah et al. · 2025 · Vaccines
  93. Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic
    Fahimeh Ranjbar Kermani, Ali Arabkhazaeli, Peyman Eshghi, Mahtab Maghsudlu, Sedigheh Amini‐Kafiabad, Amir Teimourpour, Mahmoud Reza Pourkarim · 2022 · Transfusion Clinique et Biologique
  94. SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread
    Pratibha Ramchandra Kale, Niharika Patel, Ekta Gupta, Meenu Bajpai · 2021 · Transfusion and Apheresis Science
  95. Reduced incidence of respiratory, gastrointestinal and malaria infections among children during the COVID-19 pandemic in Western Kenya: An analysis of facility-based and weekly diaries data
    Gloria P. Gómez-Pérez, Richard de Groot, Amanuel Alemu Abajobir, Caroline Wainaina, Tobias F. Rinke de Wit, Estelle Sidze, Menno Pradhan, Wendy Janssens · 2023 · Journal of Global Health
  96. SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021
    Dagmar Alber, Fadima Cheick Haidara, Juho Luoma, Laura Adubra, Per Ashorn, Ulla Ashorn, Henry Badji, Elaine Cloutman-Green, Fatoumata Diallo, Rikhard Ihamuotila et al. · 2022 · BMJ Open
  97. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients
    Bandar Alosaimi, Asif Naeem, Majed F. Alghoribi, Liliane Okdah, Maaweya E. Hamed, Ahmad S. AlYami, Athari Alotaibi, Mushira A. Enani · 2021 · Viruses
  98. Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens
    2021
  99. High anti-SARS-CoV-2 seroprevalence among unvaccinated mother–child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19
    O. Msemo, L. Pérez-Alós, Daniel T. R. Minja, C. B. Hansen, S. Gesase, G. Mtove, J. Mbwana, V. Larsen, Emilie Caroline Skuladottir Bøgestad, L. Grunnet et al. · 2022 · IJID Regions
  100. Clinical evaluation of commercial SARS-CoV-2 serological assays in a malaria endemic setting
    Djénéba Dabitao, Kathryn Shaw‐Saliba, Drissa S Konate, Helene C. Highbarger, Perrine Lallemand, Ibrahim Sanogo, Tauseef Rehman, Mamadou Wague, Nadie Coulibaly, Bourahima Kone et al. · 2023 · Journal of Immunological Methods